Fowlkes AL, Yoon SK, Lutrick K, Gwynn L, et al. Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing
SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15
Years - PROTECT Cohort, July 2021-February 2022. MMWR Morb Mortal Wkly Rep 2022;71:422-428.
PMID: 35298453